AMPL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Amplitude Inc (AMPL) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. While the stock has shown a significant price increase recently and has some positive developments, the financial performance, technical indicators, and analyst sentiment suggest a cautious approach. Holding the stock or waiting for further clarity on its growth trajectory may be more prudent.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral at 57.651, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its resistance level of 7.495, which could limit further short-term upside. Overall, the technical indicators are mixed, with no strong buy signal.
Amplitude reported a 17% YoY revenue increase in Q4 2025 and launched the Agentic AI Analytics platform, which could drive future growth. The company also exceeded analyst expectations for Q4 earnings and revenue. Additionally, the stock has shown strong recent price momentum with a 9.76% regular market gain.
Net income and EPS have declined significantly YoY, with net income down 45.82% and EPS down 50%. Gross margin has slightly decreased, and the company's valuation metrics are unavailable. Analyst price targets have been consistently lowered, reflecting cautious sentiment. Hedge funds and insiders show no significant trading activity, and there is no recent congress trading data.
In Q4 2025, revenue increased by 17.02% YoY to $91.4 million. However, net income dropped by 45.82% YoY to -$17.656 million, and EPS declined by 50% to -$0.13. Gross margin slightly decreased to 74.63%. While revenue growth is strong, profitability metrics are weak, raising concerns about the company's ability to generate sustainable earnings.
Analyst sentiment is mixed but leans cautious. Recent price target adjustments have mostly been downward, with targets ranging from $9 to $20. While some analysts highlight strong topline growth and product momentum, concerns about low margins and limited profitability persist. The overall rating trend suggests a neutral to slightly positive outlook, but not a strong buy consensus.
